ADMANasdaq United States
Market cap
$2.217 B
$9.90 -1.59%
Close of 7 Aug 2026
Revenue
$510.2M
#1900 by revenue
Earnings
$146.9M
#1146 by earnings
Shares outstanding
223,984,680
Latest filing cover page
P/E ratio
15.1
Cap ÷ net income
Where these numbers come from
Share counts and financials for Adma Biologics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.